Navigation Links
Fatty Fish consumption may reduce Kidney Cancer risk

gist at the Greater Los Angeles VA Healthcare System. The study featured in the Jan. 25 issue of Journal of the American Medical Association.

"Kidney cancer isn't that common in the United States, ranking No. 7 for men and not making the top 10 cancers for women. So the public health impact is not as great as it would be, say, for breast, lung, prostate," Calle said. "But, in terms of general interest, if [fatty fish] were associated with a decreased risk of additional cancers, that would be a very important message," she added.

"You can't go wrong eating fish," Calle said, "the American Cancer Society does not have specific recommendations on the type of fish to eat. As more data become available, our dietary recommendations are reviewed and updated."
GYT
'"/>




Page: 1 2 3

Related medicine news :

1. Importance of Fatty food In Hypercholestrolemia
2. Fatty deposits affect the stomach too
3. Soluble Ingredient Can Make Fatty Fast Foods Healthier
4. The Benefits of Omega -3 Fatty acids
5. Slowing Down The Progression Of Tumour Cells With Omega-6 Fatty Acids
6. Soy Protein Rich Diet May Help Fatty Liver Of Diabetics
7. Omega 3 Fatty acids (fishy oil) Inhibits Breast Cancer Growth
8. Persons With Fatty Liver More Prone For Hypertension
9. Efficacy of Omega 3 Fatty Acids Needs Wider Perspective
10. Fatty Acids In Fish Oil Helps Fight Obesity
11. Altering Fatty Acid Levels in Diet May Reduce Prostate Cancer Growth Rate
Post Your Comments:
(Date:1/9/2009)...DETROIT, Jan. 9 The first class of...nt program for displaced auto workers is underway...., Henry Ford developed the program,to assist thos...ng shortage.,The U.S. Bureau of Labor Statistics ...ement nurses will be needed by 2012. , Oak...
(Date:1/9/2009)...Deal Means an Additional 480 positions , , CAMP...re Services has been selected by The Centers for M...icare fee-for-service claims from hospitals and o...h care practitioners in Ohio and Kentucky. , ,...e Health and Hospice (HH&H) Medicare fee-for-s...
(Date:1/9/2009)...AHASSEE, Fla. -- A unique discovery in a Florida S...the basis for research with the potential to one d...her diseases in the tissue where they are forming....ical sciences at the College of Medicine, has rece...onal Institutes of Health to pursue her work. Hora...
(Date:1/9/2009)...th rare gene have disease relapse often within 5 y...an. 9 (HealthDay News) -- Researchers say they hav...a that does not respond well to treatment. , Th...ia (ALL) have a BCR-ABL1 fusion gene. In the Dutch...diagnosed with ALL, those with this gene tended to...
Breaking Medicine News(10 mins):Health News:Highmark Medicare Services Awarded New Contract from Centers for Medicare & Medicaid Services 2Health News:Highmark Medicare Services Awarded New Contract from Centers for Medicare & Medicaid Services 3Health News:Researcher wins $1.2 million grant for gene regulation work 2Health News:Childhood Leukemia Subtype Resists Treatment 2
...in the levels of insulin can raise the level of in...Disease. The study is being published by Archives ... hyper-insulinemia are associated with elevated le...rease the risk for Alzheimer disease (AD). Inflamm...
...ieved that almost one-third of all cancers are pre...habits. Exercising regularly and loosing excess we...ve fiber rich food. The National Cancer Institute ...ets rich in fruits and vegetables may reduce the r...
... and stutent multi-kinase inhibitors against cance...gs gained more appreciation in this years ASCO (Am...his drug is gaining interest due to its multiple m...tors. These drugs are in trial against different t...
...en found that the verbal IQ levels of children exp...ly lower than children who were not exposed to the...etween the ages of 6 and 16 who were born to mothe... on both the mother and child to produce a neurops...
Other Medicine News:Health News:Top Ten Super Food Items That Can Help In Avoiding Cancer 2
(Date:1/8/2009)... indication with clinical-stage, systemically admi...Calif., Jan. 8 Quark Pharmaceutica...ny discovering and developing novel RNA interferen... it has initiated patient dosing in its Phase I/II...stered siRNA drug candidate QPI-1002 (previously r...
(Date:1/8/2009)...ongoing Phase Ib trial demonstrated a 2.5 log10 me...nference Call Today at 8:30AM EST , , SAN DIEG...euticals, Inc. (Nasdaq: ANDS ) today announced r...b clinical trial of ANA598, the Company,s investig...98 was very well-tolerated and demonstrated potent...
(Date:1/7/2009)...est Life Sciences announced today the successful s...ug Administration to initiate human clinical trial...-0410. ImQuest anticipates initiating their Phase ...s a novel small molecule inhibitor of HIV which pr...ase inhibitor (NNRTI). The compound possesses a se...
(Date:1/6/2009)...prior U.S., U.K. and China Trials , , SAN DIEGO...I), a development stage company targeting liver di...n for a randomized, controlled, multi-center, Phas...eal Liver Assist Device (ELAD) as a treatment for ...e protocols. The study is open for enrollment at s...
Breaking Medicine Technology:Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Four Independent Research Groups Present Data Generated by Pressure Cycling Technology 28PCT 29 at the ASMS Conference on Mass Spectrometry and Allie 5886 1Four Independent Research Groups Present Data Generated by Pressure Cycling Technology 28PCT 29 at the ASMS Conference on Mass Spectrometry and Allie 5886 2Four Independent Research Groups Present Data Generated by Pressure Cycling Technology 28PCT 29 at the ASMS Conference on Mass Spectrometry and Allie 5886 3Four Independent Research Groups Present Data Generated by Pressure Cycling Technology 28PCT 29 at the ASMS Conference on Mass Spectrometry and Allie 5886 4CEL SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference 21315 1CEL SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference 21315 2CEL SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference 21315 3Women who gain excessive weight during pregnancy 21310 1Women who gain excessive weight during pregnancy 21310 2Sutter Shines in Comprehensive Quality Survey by Institute for Medical Quality 21305 1Sutter Shines in Comprehensive Quality Survey by Institute for Medical Quality 21305 2
...ns Today at 11:00 a.m. Eastern Time, LONDON, April...tion plc ("Amarin" or the "Company") today announc...l trials of Miraxion,to treat Huntington,s disease...blind, placebo-controlled studies in which HD pati...2 grams (1 gram twice,daily) of Miraxion daily for...
...UTLEY, N.J., April 23, 2007 /PRNewswire/ --,An act...enal anemia,treatment administered once every four...oetin alfa, hemodialysis centers may save an,estim...ear per 100,patients. These data, from a multi-cen...emodialysis patients, were presented today,during ...
Other Medicine Technology:Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease 2Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease 3Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease 4Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease 5Prospective Model Outlined Potential Time and Cost Savings of,Once-Monthly Anemia Treatment 2Prospective Model Outlined Potential Time and Cost Savings of,Once-Monthly Anemia Treatment 3
Model 8624 is UL Listed, CSA Certified, CE Marked. Thermo Forma Plasma Freezers safely store single donor, fresh frozen plasma, and cryoprecipitate. Recorders are standard. Cold wall refrigeration sy
Single stage hermetically sealed refrigeration system with static freezing of the cabinet interior achieving -35C*. This is fitted with a Thermoscan TS-2000 alarm monitoring system and the TCR-115 ci
Forma 1400 Series Biosafety Cabinets are designed specifically to revolutionize working in a biological safety cabinet. The most comfortable, quiet, and well lit Class II cabinet on the market, incor
Velcro® Tracheostomy tube holders are available in Adult, pediatric, and infant sizes.
Medicine Products: